SAN ANTONIO, Jan. 25, 2005 (PRIMEZONE) -- FaceKey Corporation (Pink Sheets:FEKY) announced that Yevgeny B. Levitov, President of FaceKey Corp., has conducted a Webcast to introduce the Company to its growing shareholder base and members of the investment community.
The interview was conducted by Evergreen Marketing, Inc and is currently available to the general public on The Green Baron Investors Society's website at www.TheGreenBaron.com in the 'CEO Webcast' Section.
The Management Webcast with Yevgeny B. Levitov of FaceKey Corp. highlights the Company's biometric solutions that provide security measures and access control to corporations and government agencies. In addition, Mr. Levitov mentions the Company's 'Time and Attendance' product which has the ability to reduce or eliminate costly accounting fraud.
To learn more about FaceKey Corp (Pink Sheets:FEKY) and its product offerings please visit www.FaceKey.com.
About FaceKey Corporation:
FaceKey Corp., headquartered in San Antonio, TX, is a biometrics technology provider whose mission is to provide supreme security measures for their customers by utilizing patented and proprietary biometric technologies that identify and allow access to authorized personnel. FaceKey's technology combines face and fingerprint recognition providing the highest level of security available, reducing fraud and providing better accountability. By combining these identification technologies, FaceKey's products are used for a wide variety of applications ranging from securing corporations' confidential areas and PC access to effectively monitoring time and attendance greatly reducing employee fraud.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies or products, delays in testing, and evaluation of products, and other risks detailed from time to time in the Company's filing with the Securities and Exchange Commission.